CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities
Net loss	$ (3,964,247)	$ (3,211,484)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	26,112	25,346
Allowance for bad debt	5,801
Amortization of debt discounts	118,771	274,426
Vesting of restricted stock units		90,000
Stock option employee compensation expense	1,235,650	990,559
Cost of repricing warrants to induce exercise		70,491
Loss on stock issued for interest	4,440
Payment by insurance company of prior period accrued litigation expense		(200,000)
Changes in assets and liabilities:
Accounts receivable	6,454	11,444
Inventories	(274,441)	(29,665)
Prepaid expenses and other current assets	12,716	21,603
Accounts payable	(30,636)	(32,669)
Deferred revenue	50,000
Accrued expenses	124,642	(4,542)
Accrual for termination and release agreement	(84,460)
Net cash used in operating activities	(2,769,198)	(1,994,491)
Cash flows from Investing Activities
Purchases of equipment	(57,093)	(3,285)
Net cash (used in) investing activities	(57,093)	(3,285)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements	775,000	128,000
Proceeds from the sale of stock and warrants through private placements	730,000
Proceeds from sale of stock under stock purchase agreement	570,000	810,003
Proceeds from exercise of warrants	25,000	910,000
Proceeds from exercise of stock options	18,200
Payments on related party notes		(59,839)
Proceeds from convertible notes with third parties		175,000
Proceeds from convertible notes with related parties	1,000,000	250,000
Repayment on convertible notes with third parties	(115,822)
Repayments on convertible notes with related parties	(85,880)
Payments on Insurance Finance Contract	(39,374)	(19,033)
Net cash provided by financing activities	2,877,124	2,194,131
Net increase in cash and cash equivalents	50,833	196,355
Cash and cash equivalents - beginning	90,275	84,194
Cash and cash equivalents - ending	141,108	280,549
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	1,219	296
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	92,846	47,471
Beneficial conversion feature of convertible notes	311,949	190,280
Loan discount from warrants	601,949
Stock issued for interest	4,440
Conversion of notes for common stock	$ 82,132	$ 332,996